Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Atypical Ductal Hyperplasia

etoposide has been researched along with Atypical Ductal Hyperplasia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, S; Endo, I; Ichikawa, Y; Ishikawa, T; Kida, K; Narui, K; Sasaki, T; Satake, T; Shimada, K; Shimizu, D; Sugae, S; Tanabe, M; Yamada, A1
Amir, G; Cohen, Y; Polliack, A; Rachmilewitz, EA1
Jun Yang, Y1
Fujita, M; Honda, I; Kawabe, T; Kawakami, Y; Matsushita, K; Ryu, M; Watanabe, K; Watanabe, S; Yoshida, M1

Other Studies

4 other study(ies) available for etoposide and Atypical Ductal Hyperplasia

ArticleYear
Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Docetaxel; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Mammaplasty; Mastectomy, Subcutaneous; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Perforator Flap; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Young Adult

2015
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Mastectomy, Segmental; Neoplasms, Multiple Primary; Orbital Neoplasms; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Vincristine

2002
Gynecomastia with marked cellular atypia associated with chemotherapy.
    Archives of pathology & laboratory medicine, 2002, Volume: 126, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms, Male; Carcinoma, Intraductal, Noninfiltrating; Cytarabine; Daunorubicin; Diagnostic Errors; Etoposide; Gynecomastia; Humans; Leukemia, Myelomonocytic, Acute; Male

2002
[Remarkable effect of the combination therapy of etoposide, epiadriamycin, and CDDP (EAP) in the treatment of metachronous lung metastases of breast cancer--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:14

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Mastectomy, Radical; Remission Induction

1991